95 related articles for article (PubMed ID: 7018679)
1. Efficacy of piperazinedione prior to bone marrow transplantation: studies in a rat model for human acute myelocytic leukemia.
Hagenbeek A; Martens AC
Cancer Treat Rep; 1981; 65(7-8):575-82. PubMed ID: 7018679
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of high-dose cyclophosphamide in combination with total-body irradiation in the treatment of acute myelocytic leukemia: studies in a relevant rat model.
Hagenbeek A; Martens AC
Cancer Res; 1983 Jan; 43(1):408-12. PubMed ID: 6336603
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-2 therapy after allogeneic bone marrow transplantation for acute myelocytic leukemia: studies in a relevant rat model for AML.
Kloosterman TC; Martens AC; Osterwalder B; Hagenbeek A
Bone Marrow Transplant; 1994 Dec; 14(6):965-73. PubMed ID: 7711675
[TBL] [Abstract][Full Text] [Related]
4. Quantitative studies on graft-versus-leukemia after allogeneic bone marrow transplantation in rat models for acute myelocytic and lymphocytic leukemia.
Kloosterman TC; Tielemans MJ; Martens AC; van Bekkum DW; Hagenbeek A
Bone Marrow Transplant; 1994 Jul; 14(1):15-22. PubMed ID: 7951103
[TBL] [Abstract][Full Text] [Related]
5. Phase I-II study of piperazinedione in adults with solid tumors and acute leukemia.
Benjamin RS; Keating MJ; Valdivieso M; McCredie KB; Livingston RA; Burgess MA; Rodriguez V; Bodey GP; Gottlieb JA
Cancer Treat Rep; 1979 Jun; 63(6):939-43. PubMed ID: 380802
[TBL] [Abstract][Full Text] [Related]
6. Influence of ultraviolet-B irradiation on engraftment, graft-versus-host disease and graft-versus-leukemia effect in a rat model for allogeneic bone marrow transplantation.
Gowing H; Braakman E; Hagenbeek A; Lawler M; McCann SR; Pamphilon DH; Martens AC
Bone Marrow Transplant; 1998 Apr; 21(8):801-7. PubMed ID: 9603404
[TBL] [Abstract][Full Text] [Related]
7. Minimal residual disease in leukemia: studies in an animal model for acute myelocytic leukemia (BNML).
Martens AC; van Bekkum DW; Hagenbeek A
Int J Cell Cloning; 1990 Jan; 8(1):27-38. PubMed ID: 2403582
[TBL] [Abstract][Full Text] [Related]
8. Graft-versus-leukemia in rat MHC-mismatched bone marrow transplantation is merely an allogeneic effect.
Kloosterman TC; Martens AC; van Bekkum DW; Hagenbeek A
Bone Marrow Transplant; 1995 Apr; 15(4):583-90. PubMed ID: 7655385
[TBL] [Abstract][Full Text] [Related]
9. The BN acute myelocytic leukemia (BNML) (a rat model for studying human acute myelocytic leukemia (AML)).
Martens AC; Van Bekkum DW; Hagenbeek A
Leukemia; 1990 Apr; 4(4):241-57. PubMed ID: 2195239
[TBL] [Abstract][Full Text] [Related]
10. Piperazinedione (NSC 135758) and total body irradiation as an ablative bone marrow transplantation regimen in mice.
Zander AR; Huynh L; Spitzer G; Verma DS; Dicke KA
Exp Hematol; 1981 Oct; 9(9):945-9. PubMed ID: 7040096
[TBL] [Abstract][Full Text] [Related]
11. Dinaline: a new oral drug against leukemia? Preclinical studies in a relevant rat model for human acute myelocytic leukemia (BNML).
Hagenbeek A; Weiershausen U; Martens AC
Leukemia; 1988 Apr; 2(4):226-30. PubMed ID: 3163079
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of acetyldinaline for treatment of minimal residual disease (MRD): preclinical studies in the BNML rat model for human acute myelocytic leukemia.
el-Beltagi HM; Martens AC; Dahab GM; Hagenbeek A
Leukemia; 1993 Nov; 7(11):1795-800. PubMed ID: 8231248
[TBL] [Abstract][Full Text] [Related]
13. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
Nestvold JM; Omdal BK; Dai KZ; Martens A; Benestad HB; Vaage JT; Rolstad B
Transplantation; 2008 Jan; 85(1):102-11. PubMed ID: 18192919
[TBL] [Abstract][Full Text] [Related]
14. Infused CD34+ cell dose predicts long-term survival in acute myelogenous leukemia patients who received allogeneic bone marrow transplantation from matched sibling donors in first complete remission.
Lee SH; Lee MH; Lee JH; Min YH; Lee KH; Cheong JW; Lee J; Park KW; Kang JH; Kim K; Kim WS; Jung CW; Choi SJ; Lee JH; Park K
Biol Blood Marrow Transplant; 2005 Feb; 11(2):122-8. PubMed ID: 15682073
[TBL] [Abstract][Full Text] [Related]
15. [Unrelated donor allogenetic marrow transplantation in treatment of acute and chronic leukemia].
Huang H; Lin M; Meng H
Zhonghua Yi Xue Za Zhi; 2001 Mar; 81(5):263-7. PubMed ID: 11798883
[TBL] [Abstract][Full Text] [Related]
16. Acetyldinaline: a new oral cytostatic drug with impressive differential activity against leukemic cells and normal stem cells--preclinical studies in a relevant rat model for human acute myelocytic leukemia.
el-Beltagi HM; Martens AC; Lelieveld P; Haroun EA; Hagenbeek A
Cancer Res; 1993 Jul; 53(13):3008-14. PubMed ID: 8319208
[TBL] [Abstract][Full Text] [Related]
17. Phase I study of cladribine, cytarabine (Ara-C), granulocyte colony stimulating factor (G-CSF) (CLAG Regimen) and simultaneous escalating doses of imatinib mesylate (Gleevec) in relapsed/refractory AML.
Walker AR; Komrokji RS; Ifthikharuddin J; Messina P; Mulford D; Becker M; Friedberg J; Oliva J; Phillips G; Liesveld JL; Abboud C
Leuk Res; 2008 Dec; 32(12):1830-6. PubMed ID: 18571721
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic bone marrow transplantation for leukemia with marrow grafts treated by counterflow centrifugation.
De Witte T; Schattenberg A; Preijers F; Raymakers R; Muus P; Wessels J
Bone Marrow Transplant; 1993; 12 Suppl 3():S2-6. PubMed ID: 8124252
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation.
Gordon BG; Warkentin PI; Strandjord SE; Abromowitch M; Bayever E; Harper JL; Coccia PF
Bone Marrow Transplant; 1997 Jul; 20(1):5-10. PubMed ID: 9232249
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic peripheral blood progenitor cells for treatment of relapse after bone marrow transplantation.
Glass B; Majolino I; Dreger P; Scimè R; Santoro A; Vasta S; Suttorp M; Haferlach T; Schmitz N
Bone Marrow Transplant; 1997 Oct; 20(7):533-41. PubMed ID: 9337054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
